Flu Shots Now Available

Flu shots are available for adult patients on our main campus 9:00 a.m. to 4:00 p.m. Monday through Friday. Patients can receive their shots at the time of their appointments as well as on a walk-in basis. Pediatric flu shots are on a by appointment basis.

  • Flu shots will be available for current National Jewish patients, not the general public. At the discretion of the physician, family members of high-risk patients may also be vaccinated. We are unable to bill insurance for family members who are not National Jewish patients; they will be required to pay at the time of service.

  • Consistent with prices in the community, we are billing $30 for the regular dose and $45 for the high dose. Patients without insurance coverage for flu shots will be required to pay at the time of service. CICP does not cover flu vaccine, and Medicaid requires patients to go to a designated location.

  • We also have high dose vaccine intended for high risk patients over 65. Patients over 65 will receive the high dose vaccine. 

  • The CDC recommends universal vaccination for everyone over six months of age.


Additional Locations:

  • Our clinic in Highlands Ranch will offer flu shots on an appointment basis.
  • Our South Denver clinic will administer shots with scheduled provider appointments and on a drop-by basis.
  • Northern Oncology and Western Oncology will administer vaccine during their regular clinic hours.


View information about how to prepare for the flu season.


ASV Device Warning

Attention Patients Using Adaptive Servo Ventilation  

Results of a recently conducted clinical trial suggest that certain patients with central sleep apnea and symptomatic heart failure should not be treated with adaptive servo ventilation (ASV) due to an associated increased risk of cardiovascular death.

If you are currently using an ASV device, (or if you're not sure what type of positive airway pressure device you are using), and have a history of heart failure, please contact your treating physician to discuss options for ongoing management of your sleep apnea.

The study findings do not apply to patients being treated with other positive airway pressure modalities such as CPAP or BiPAP, but if you have any questions or concerns you are advised to consult with your treating physician.


Manufacturer warning messages:


Ebola Virus Update – Preparations and Training at National Jewish Health

 National Jewish Heath continues to monitor the latest information and recommendations regarding the Ebola virus. We are committed to thorough preparations for responding to anyone potentially infected with the virus.
Physicians and medical staff are prepared to care safely for patients with highly infectious diseases such as Ebola. They have completed all steps recommended by the U.S. Centers for Disease Control and Prevention (CDC) and the Colorado Department of Public Health and Environment (CDPHE) for recognizing and responding to people at risk for Ebola infection.
Currently, National Jewish Health is screening all patients for risk factors and symptoms of infection with the Ebola virus. Patients should be aware that they will be asked to disclose travel history to West Africa, along with any symptoms of infectious disease that may be present when they check in at National Jewish Health. Thank you in advance for your patience with this added step to your check-in process.
For more information regarding Ebola symptoms and prevention please visit the CDC website.
At National Jewish Health, the health and safety of patients and their families is our top concern.
Jeffrey M. Downing, MS, RN
Chief Nursing Officer
National Jewish Health


Duoedenoscope Issue

Recently you may have seen warnings from the FDA about a possible infection acquired through a GI procedure called an ERCP, which is performed with a special device called a duoedenoscope. A duodenoscope is a special camera used mainly for ERCPs, and is not used at National Jewish Health for any procedures.

In addition, National Jewish Health has never had a case of an endoscopy-related infection due to inadequate sterilization.

If you have further questions, please contact Renee Mondragon-Miller, the director of our procedure center, at 303.270.2537 who would be glad to discuss our operations and state of the art processes for equipment sterilization.


Zika Virus Disease


About Zika Virus Disease

Zika virus disease (Zika) is caused by the Zika virus which is transmitted to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis (red eyes). Illness is usually mild and lasts for several days to a week after being bitten by an infected mosquito. People are rarely sick enough to seek medical care.


Zika, Pregnancy and Sexual Transmission

Zika virus infection during pregnancy can cause microcephaly and other severe fetal brain defects. While Zika is primarily spread through mosquitoes, it is known that a man can also spread Zika to his sex partners. It is currently unknown if a pregnant woman is infected by mosquito bite or sexual contact, how likely it is that the virus will infect the fetus and cause birth defects. There are many things we do not know about Zika and sexual transmission, including how long Zika Virus can persist in semen.


Prevention of Zika

There are no vaccines to prevent Zika and no medicine to treat Zika. Anyone traveling to areas of Zika transmission should strictly follow steps to prevent mosquito bites including protective clothing and mosquito repellant. To prevent potential severe birth defects, pregnant women should avoid travel to areas with Zika transmission. Pregnant women with male sex partners that live or travel to an area with Zika should use condoms every time they have sex or avoid sex during pregnancy.



Zika in the United States

As of May 11, 2016 there were 503 travel-associated cases of Zika reported in the US including 48 in pregnant women and 10 sexually transmitted cases. There have been no locally-acquired mosquito-borne cases reported. The map to the left indicates the estimated range of the Aedes aegypti mosquito which are the most likely to spread Zika virus. The risk of mosquito spread of Zika in the US is still unknown but public health officials are currently working on mosquito control programs to prevent potential wide-spread transmission.


Infection Prevention in Healthcare Settings

Healthcare workers must follow standard precautions including hand hygiene, safe injection practices, and the use of personal protective equipment (PPE) to avoid direct contact with blood and other potentially infectious materials from all patients. These precautions prevent exposure to Zika Virus in the healthcare setting. Laboratory personnel must also ensure practices meet the appropriate Biosafety Level (BSL) for the type of work being conducted.

Information on Zika is rapidly being updated as we learn more. For up-to-date Zika Information: